风湿免疫科指南

订阅

MedSci主页 / 所有栏目 / 风湿免疫科指南

2019 HKSR共识建议：类风湿性关节炎的管理

2019-09-04 香港风湿病学会 Clin Rheumatol. 2019 Sep 4.

类风湿性关节炎

2019年9月，香港风湿病学会(HKSR)发布了类风湿性关节炎的管理建议，类风湿性关节炎治疗选择范围的扩大改善了患者的结局但增加了治疗决策的复杂性。本文主要针对类风湿性关节炎的诊断和治疗提供指导建议。

中文标题：

2019 HKSR共识建议：类风湿性关节炎的管理

英文标题：

Management of rheumatoid arthritis: 2019 updated consensus recommendations from the Hong Kong Society of Rheumatology.

发布机构：

香港风湿病学会

发布日期：

2019-09-04

简要介绍：

2019年9月，香港风湿病学会(HKSR)发布了类风湿性关节炎的管理建议，类风湿性关节炎治疗选择范围的扩大改善了患者的结局但增加了治疗决策的复杂性。本文主要针对类风湿性关节炎的诊断和治疗提供指导建议。

 

拓展指南：与类风湿性关节炎相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2019 HKSR共识建议：类风湿性关节炎的管理)] GetToolGuiderByIdResponse(projectId=1, id=b0c4f1c001e9a274, title=2019 HKSR共识建议：类风湿性关节炎的管理, enTitle=Management of rheumatoid arthritis: 2019 updated consensus recommendations from the Hong Kong Society of Rheumatology., guiderFrom=Clin Rheumatol. 2019 Sep 4., authorId=null, author=, summary=2019年9月，香港风湿病学会(HKSR)发布了类风湿性关节炎的管理建议，类风湿性关节炎治疗选择范围的扩大改善了患者的结局但增加了治疗决策的复杂性。本文主要针对类风湿性关节炎的诊断和治疗提供指导建议。 , cover=, journalId=null, articlesId=null, associationId=1828, associationName=香港风湿病学会, associationIntro=, copyright=0, guiderPublishedTime=Wed Sep 04 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年9月，香港风湿病学会(HKSR)发布了类风湿性关节炎的管理建议，类风湿性关节炎治疗选择范围的扩大改善了患者的结局但增加了治疗决策的复杂性。本文主要针对类风湿性关节炎的诊断和治疗提供指导建议。 </P> <P> </P>拓展指南：<STRONG>与<FONT color=red>类风湿性关节炎</FONT>相关指南：</STRONG><BR> <UL> <LI><A title="2018 APLAR建议：类风湿性关节炎的治疗（更新版）" target=_blank href="https://www.medsci.cn/guideline/show_article.do?id=bed7e1c001e12a8a">2018 APLAR建议：类风湿性关节炎的治疗（更新版）</A> <LI><A title="2018 意大利共识建议：类风湿性关节炎丙型肝炎感染的管理" target=_blank href="https://www.medsci.cn/guideline/show_article.do?id=d67fd1c0016836cc">2018 意大利共识建议：类风湿性关节炎丙型肝炎感染的管理</A> <LI><A title="2018 SFR建议：类风湿性关节炎的管理（更新）" target=_blank href="https://www.medsci.cn/guideline/show_article.do?id=c4c9e1c00165282c">2018 SFR建议：类风湿性关节炎的管理（更新）</A> <LI><A title="2018 多学科建议：类风湿性关节炎患者足部问题的诊断和治疗" target=_blank href="https://www.medsci.cn/guideline/show_article.do?id=9542f1c001615e3f">2018 多学科建议：类风湿性关节炎患者足部问题的诊断和治疗</A> <LI><A title="2017 EULAR建议：支持观察研究的核心数据集和类风湿性关节炎的临床护理" target=_blank href="https://www.medsci.cn/guideline/show_article.do?id=cd2cb1c0015a14d5">2017 EULAR建议：支持观察研究的核心数据集和类风湿性关节炎的临床护理</A> 更多信息请点击：<A target=_blank href="https://www.medsci.cn/guideline/list.do?q=%E7%B1%BB%E9%A3%8E%E6%B9%BF%E6%80%A7%E5%85%B3%E8%8A%82%E7%82%8E">有关类风湿性关节炎更多指南</A></LI></UL>, tagList=[TagDto(tagId=2259, tagName=类风湿性关节炎)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5107, appHits=644, showAppHits=18, pcHits=2818, showPcHits=2453, likes=113, shares=16, comments=6, approvalStatus=1, publishedTime=Sun Sep 22 22:36:57 CST 2019, publishedTimeString=2019-09-04, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Sep 22 22:36:57 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 14:02:28 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 HKSR共识建议：类风湿性关节炎的管理)])
2019 HKSR共识建议：类风湿性关节炎的管理
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2101280, encodeId=aad6210128018, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26638432949, createdName=ms9000000187836854, createdTime=Fri Nov 18 10:40:18 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978942, encodeId=f7cd9e8942e6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3505535937, createdName=ms1000000783007837, createdTime=Fri Jul 02 11:12:15 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978940, encodeId=9d5e9e8940b8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3505535937, createdName=ms1000000783007837, createdTime=Fri Jul 02 11:10:41 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973434, encodeId=ee079e343497, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91111899745, createdName=ms8864469033539732, createdTime=Mon Jun 14 12:43:25 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967628, encodeId=3e4296e62846, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5dcc1688899, createdName=1de51f7bm72(暂无匿称), createdTime=Fri May 21 23:33:21 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2022-11-18 ms9000000187836854

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2101280, encodeId=aad6210128018, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26638432949, createdName=ms9000000187836854, createdTime=Fri Nov 18 10:40:18 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978942, encodeId=f7cd9e8942e6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3505535937, createdName=ms1000000783007837, createdTime=Fri Jul 02 11:12:15 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978940, encodeId=9d5e9e8940b8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3505535937, createdName=ms1000000783007837, createdTime=Fri Jul 02 11:10:41 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973434, encodeId=ee079e343497, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91111899745, createdName=ms8864469033539732, createdTime=Mon Jun 14 12:43:25 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967628, encodeId=3e4296e62846, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5dcc1688899, createdName=1de51f7bm72(暂无匿称), createdTime=Fri May 21 23:33:21 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2021-07-02 ms1000000783007837

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2101280, encodeId=aad6210128018, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26638432949, createdName=ms9000000187836854, createdTime=Fri Nov 18 10:40:18 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978942, encodeId=f7cd9e8942e6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3505535937, createdName=ms1000000783007837, createdTime=Fri Jul 02 11:12:15 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978940, encodeId=9d5e9e8940b8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3505535937, createdName=ms1000000783007837, createdTime=Fri Jul 02 11:10:41 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973434, encodeId=ee079e343497, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91111899745, createdName=ms8864469033539732, createdTime=Mon Jun 14 12:43:25 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967628, encodeId=3e4296e62846, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5dcc1688899, createdName=1de51f7bm72(暂无匿称), createdTime=Fri May 21 23:33:21 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2021-07-02 ms1000000783007837

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2101280, encodeId=aad6210128018, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26638432949, createdName=ms9000000187836854, createdTime=Fri Nov 18 10:40:18 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978942, encodeId=f7cd9e8942e6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3505535937, createdName=ms1000000783007837, createdTime=Fri Jul 02 11:12:15 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978940, encodeId=9d5e9e8940b8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3505535937, createdName=ms1000000783007837, createdTime=Fri Jul 02 11:10:41 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973434, encodeId=ee079e343497, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91111899745, createdName=ms8864469033539732, createdTime=Mon Jun 14 12:43:25 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967628, encodeId=3e4296e62846, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5dcc1688899, createdName=1de51f7bm72(暂无匿称), createdTime=Fri May 21 23:33:21 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2021-06-14 ms8864469033539732

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2101280, encodeId=aad6210128018, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26638432949, createdName=ms9000000187836854, createdTime=Fri Nov 18 10:40:18 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978942, encodeId=f7cd9e8942e6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3505535937, createdName=ms1000000783007837, createdTime=Fri Jul 02 11:12:15 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978940, encodeId=9d5e9e8940b8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3505535937, createdName=ms1000000783007837, createdTime=Fri Jul 02 11:10:41 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973434, encodeId=ee079e343497, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91111899745, createdName=ms8864469033539732, createdTime=Mon Jun 14 12:43:25 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967628, encodeId=3e4296e62846, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5dcc1688899, createdName=1de51f7bm72(暂无匿称), createdTime=Fri May 21 23:33:21 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2021-05-21 1de51f7bm72(暂无匿称)

    学习

    0

相关指南

2018 APLAR建议：类风湿性关节炎的治疗（更新版）

亚太风湿病学联盟协会(APLAR,Asia Pacific League of Associations for Rheumatology) · 2019-02-27

2018 意大利共识建议：类风湿性关节炎丙型肝炎感染的管理

意大利风湿病学学会(SIR,Italian Society of Rheumatology) · 2018-12-22

2018 SFR建议：类风湿性关节炎的管理（更新）

法国风湿病学学会(SFR,French Society for Rheumatology) · 2018-10-10

2018 多学科建议：类风湿性关节炎患者足部问题的诊断和治疗

国外风湿免疫科相关专家小组 · 2018-07-04

2017 EULAR建议：支持观察研究的核心数据集和类风湿性关节炎的临床护理

欧洲抗风湿病联盟(EULAR,The European League Against Rheumatism) · 2018-01-04

《2017年意大利共识指南：类风湿性关节炎患者HBV感染的管理》摘译

暂未更新 · 2017-11-05